FHIR IG Statistics: ValueSet/2.16.840.1.113762.1.4.1235.332
| Package | us.nlm.vsac |
| Resource Type | ValueSet |
| Id | 2.16.840.1.113762.1.4.1235.332 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1235.332/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.332 |
| Version | 20230616 |
| Status | active |
| Date | 2023-06-16T01:00:56-04:00 |
| Name | HighRiskHPVTest_HD_Grouping |
| Title | High Risk HPV Test_HD_Grouping |
| Realm | us |
| Authority | hl7 |
| Description | b.well created value set by Sr. Clinical Business Analyst for High Risk HPV Test. |
| Purpose | (Clinical Focus: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.),(Data Element Scope: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.),(Inclusion Criteria: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.),(Exclusion Criteria: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.) |
Resources that use this resource
No resources found
Resources that this resource uses
| CodeSystem |
| loinc.org | LOINC Code System |
| sct | SNOMED CT (all versions) |
| cpt | Current Procedural Terminology (CPT®) |
| HCPCSReleaseCodeSets | Healthcare Common Procedure Coding System (HCPCS) level II alphanumeric codes |
Narrative
No narrative content found in resource
Source
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113762.1.4.1235.332",
"meta": {
"versionId": "6",
"lastUpdated": "2023-12-21T17:43:03.000-05:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "B.well Connected Health Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2024-07-02"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2023-06-16"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.332",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113762.1.4.1235.332"
}
],
"version": "20230616",
"name": "HighRiskHPVTest_HD_Grouping",
"title": "High Risk HPV Test_HD_Grouping",
"status": "active",
"date": "2023-06-16T01:00:56-04:00",
"publisher": "B.well Connected Health Steward",
"description": "b.well created value set by Sr. Clinical Business Analyst for High Risk HPV Test.",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.),(Data Element Scope: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.),(Inclusion Criteria: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.),(Exclusion Criteria: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.)",
"compose": {
"include": [
{
"valueSet": [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.328"
]
},
{
"valueSet": [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.329"
]
},
{
"valueSet": [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.330"
]
},
{
"valueSet": [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.331"
]
}
]
},
"expansion": {
"identifier": "urn:uuid:74a78d61-1b95-4c6e-8e19-72b30aaf2ea4",
"timestamp": "2025-05-23T20:23:15-04:00",
"total": 24,
"contains": [
{
"system": "http://loinc.org",
"version": "2.80",
"code": "21440-3",
"display": "Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA [Presence] in Cervix by Probe"
},
{
"system": "http://loinc.org",
"version": "2.80",
"code": "30167-1",
"display": "Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification"
},
{
"system": "http://snomed.info/sct",
"version": "http://snomed.info/sct/731000124108/version/20250301",
"code": "35904009",
"display": "Human papillomavirus deoxyribonucleic acid detection (procedure)"
},
{
"system": "http://loinc.org",
"version": "2.80",
"code": "38372-9",
"display": "Human papilloma virus 6+11+16+18+31+33+35+39+42+43+44+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification"
},
{
"system": "http://snomed.info/sct",
"version": "http://snomed.info/sct/731000124108/version/20250301",
"code": "441667007",
"display": "Abnormal cervical Papanicolaou smear with human papillomavirus deoxyribonucleic acid detected (finding)"
},
{
"system": "http://snomed.info/sct",
"version": "http://snomed.info/sct/731000124108/version/20250301",
"code": "448651000124104",
"display": "Microscopic examination of cervical Papanicolaou smear and Human papillomavirus deoxyribonucleic acid detection cotesting (procedure)"
},
{
"system": "http://loinc.org",
"version": "2.80",
"code": "59263-4",
"display": "Human papilloma virus 16 DNA [Presence] in Cervix by Probe with signal amplification"
},
{
"system": "http://loinc.org",
"version": "2.80",
"code": "59264-2",
"display": "Human papilloma virus 18 DNA [Presence] in Cervix by Probe with signal amplification"
},
{
"system": "http://loinc.org",
"version": "2.80",
"code": "59420-0",
"display": "Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by Probe with signal amplification"
},
{
"system": "http://loinc.org",
"version": "2.80",
"code": "69002-4",
"display": "Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection"
},
{
"system": "http://loinc.org",
"version": "2.80",
"code": "71431-1",
"display": "Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection"
},
{
"system": "http://snomed.info/sct",
"version": "http://snomed.info/sct/731000124108/version/20250301",
"code": "718591004",
"display": "High risk human papillomavirus detected by cytology (finding)"
},
{
"system": "http://snomed.info/sct",
"version": "http://snomed.info/sct/731000124108/version/20250301",
"code": "720005005",
"display": "Human papillomavirus deoxyribonucleic acid detected, high risk on cervical specimen (finding)"
},
{
"system": "http://loinc.org",
"version": "2.80",
"code": "75694-0",
"display": "Human papilloma virus 18+45 E6+E7 mRNA [Presence] in Cervix by NAA with probe detection"
},
{
"system": "http://loinc.org",
"version": "2.80",
"code": "77379-6",
"display": "Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Interpretation] in Cervix"
},
{
"system": "http://loinc.org",
"version": "2.80",
"code": "77399-4",
"display": "Human papilloma virus 16 DNA [Presence] in Cervix by NAA with probe detection"
},
{
"system": "http://loinc.org",
"version": "2.80",
"code": "77400-0",
"display": "Human papilloma virus 18 DNA [Presence] in Cervix by NAA with probe detection"
},
{
"system": "http://loinc.org",
"version": "2.80",
"code": "82354-2",
"display": "Human papilloma virus 16 and 18+45 E6+E7 mRNA [Identifier] in Cervix by NAA with probe detection"
},
{
"system": "http://loinc.org",
"version": "2.80",
"code": "82456-5",
"display": "Human papilloma virus 16 E6+E7 mRNA [Presence] in Cervix by NAA with probe detection"
},
{
"system": "http://loinc.org",
"version": "2.80",
"code": "82675-0",
"display": "Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "87624",
"display": "Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), high-risk types (eg, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68), pooled result"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "87625",
"display": "Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), types 16 and 18 only, includes type 45, if performed"
},
{
"system": "http://loinc.org",
"version": "2.80",
"code": "95539-3",
"display": "Human papilloma virus 31 DNA [Presence] in Cervix by NAA with probe detection"
},
{
"system": "http://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets",
"version": "2025",
"code": "G0476",
"display": "Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test"
}
]
}
}
FHIR